8-K: FitLife Brands Reports Strong Q4 and Full-Year 2024 Results, Fueled by Online Sales Growth

FitLife Brands announces a 13% increase in Q4 revenue and a 22% increase in full-year revenue, driven by strong online sales and strategic acquisitions.

Summary

• FitLife Brands reported its financial results for the fourth quarter and full year ended December 31, 2024.
• Total revenue for Q4 2024 was $15.0 million, a 13% increase compared to Q4 2023.
• Online sales in Q4 2024 reached $10.1 million, representing 67% of total revenue, a 12% increase year-over-year.
• Gross margin for Q4 2024 was 41.4%, up from 40.3% in Q4 2023.
• Net income for Q4 2024 was $2.1 million, compared to $1.5 million in the same period last year.
• Basic earnings per share were $0.23, and diluted earnings per share were $0.21 for Q4 2024.
• Adjusted EBITDA for Q4 2024 was $3.1 million, a 31% increase compared to Q4 2023.
• For the full year 2024, total revenue was $64.5 million, a 22% increase compared to 2023.
• Online sales for the full year were $43.0 million, representing 67% of total revenue, a 29% increase year-over-year.
• Gross margin for the full year was 43.6%, compared to 40.7% in 2023.
• Net income for the full year was $9.0 million, a 70% increase from the prior year.
• Basic earnings per share increased 66% to $0.98, and diluted earnings per share increased 69% to $0.91 for the full year.
• Adjusted EBITDA for the full year was $14.1 million, a 39% increase compared to $10.2 million in the prior year.
• The company ended the year with $13.1 million outstanding on its term loans and $4.5 million in cash, resulting in net debt of $8.6 million, equivalent to 0.6x adjusted EBITDA.
• For the first quarter of 2025, the company anticipates a revenue decline of approximately 4-6%, but expects adjusted EBITDA to be approximately flat compared to the first quarter of 2024.
• For the full year ended December 31, 2025, the Company expects to deliver organic revenue and EBITDA growth.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results and strategic initiatives. While there are some challenges noted, the overall tone is optimistic, reflecting confidence in the company's future performance.

Positives

• Significant revenue growth in both Q4 and full-year 2024.
• Strong performance in online sales, representing a substantial portion of total revenue.
• Improved gross margins in both Q4 and full-year 2024.
• Substantial increase in net income for both Q4 and full-year 2024.
• Significant growth in adjusted EBITDA for both Q4 and full-year 2024.
• The company has a strong balance sheet with low net debt relative to adjusted EBITDA.
• MusclePharm revenue increased 14% sequentially from the third quarter of 2024 to the fourth quarter of 2024.
• The company has repaid $9.4 million of borrowings used to fund the purchase of MRC and the MusclePharm assets.

Negatives

• Legacy FitLife revenue declined 13% in Q4 2024, driven by a 20% decline in wholesale revenue and a 1% decrease in online revenue.
• A commercial dispute with GNC resulted in the company rejecting purchase orders from December 1, 2024, impacting wholesale revenue.
• The company anticipates a revenue decline of approximately 4-6% for the first quarter of 2025.
• Online revenue for MRC is expected to decline approximately 10-13% for the first quarter of 2025.
• Gross margin for MusclePharm decreased to 26.5% in the fourth quarter of 2024.

Risks

• Potential impact of tariffs on goods coming from China, which could increase the company's cost of goods sold.
• The company's wholesale revenue continues to be challenged by declining customer counts in the brick-and-mortar stores of wholesale partners.
• The company's future performance is subject to risks and uncertainties, including the ability to continue to grow revenue and achieve positive cash flow.
• The company is exposed to recessionary concerns and uncertainty related to tariffs.

Future Outlook

The company anticipates a revenue decline of approximately 4-6% for the first quarter of 2025 but expects adjusted EBITDA to be approximately flat compared to the first quarter of 2024. For the full year ended December 31, 2025, the Company expects to deliver organic revenue and EBITDA growth.

Management Comments

• Dayton Judd, the Company's Chairman and CEO, stated that he is pleased with the Company's progress in 2024.
• Dayton Judd noted that the company has been opportunistically acquiring certain raw materials at pre-tariff prices to use in future production to mitigate the potential impact of tariffs.
• Dayton Judd believes that one potential benefit of the current economic uncertainty could be increased M&A opportunities for the Company, potentially at lower valuations.
• Dayton Judd is proud of what the FitLife team accomplished in 2024 and is excited about future opportunities for the brands and the company.
• Dayton Judd stated that the company's balance sheet is strong and continues to get stronger as it generates additional cash, enhancing the company's flexibility as it pursues additional M&A opportunities.

Industry Context

FitLife Brands operates in the competitive nutritional supplements and wellness products market. The company's focus on online sales aligns with the broader trend of e-commerce growth in the health and wellness sector. The acquisition of MRC and MusclePharm assets reflects a strategy to expand its brand portfolio and market reach. The company's comments on tariffs and M&A opportunities indicate an awareness of macroeconomic factors and a proactive approach to managing costs and pursuing growth opportunities.

Comparison to Industry Standards

• FitLife's revenue growth of 22% for the full year 2024 is strong compared to the overall nutritional supplements market, which has seen more moderate growth.
• Companies like Herbalife Nutrition and Nu Skin Enterprises have reported varying growth rates, with some facing challenges in certain regions.
• FitLife's focus on online sales aligns with the strategies of companies like Amazon and iHerb, which have a significant presence in the online health and wellness market.
• The adjusted EBITDA margin of FitLife Brands is competitive with industry peers.
• The company's net debt to adjusted EBITDA ratio of 0.6x indicates a healthy financial position compared to some competitors with higher leverage.

Stakeholder Impact

• Shareholders will likely react positively to the strong financial results and growth prospects.
• Employees may benefit from the company's continued success and expansion.
• Customers can expect new product launches and continued innovation.
• Suppliers may see increased demand for raw materials and components.
• Creditors are likely to view the company's strong balance sheet and low leverage favorably.

Next Steps

• The company intends to continue providing elevated marketing support for the MusclePharm products in future quarters.
• The company will continue rolling out the new packaging for the legacy MusclePharm products through the first half of 2025.
• The company will monitor the pilot effort of the MusclePharm Pro Series in Vitamin Shoppe stores and potentially expand it to all stores.
• The company is in the process of presenting the RTDs to its existing wholesale customers.
• The company will continue to monitor and mitigate the potential impact of tariffs on goods coming from China.
• The company will continue to pursue additional M&A opportunities.

Key Dates

Keywords

FitLife Brands, Financial Results, Nutritional Supplements, Wellness Products, Online Sales, Adjusted EBITDA, Revenue Growth, Gross Margin, Net Income, MusclePharm, Mimi's Rock, FTLF